Respiratory Syncytial Virus (RSV) Vaccination

Author/Reviewer:

Honey Joseph, PharmD, BCPS—Author
Clinical Assistant Professor
Drug Information Group
University of Illinois at Chicago, College of Pharmacy

Robert Rosman, MD—Reviewer
Associate Professor of Clinical Medicine
University of Illinois at Chicago College of Medicine

Disclosure (s):
Drs. Joseph and Rosman, the planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.

Learning Objectives:

At the end of this knowledge-based activity, participating individuals should be able to:

• Describe the pathogenesis, epidemiology, and clinical presentation of respiratory syncytial virus (RSV).
• Discuss and compare the currently available RSV vaccines, including mechanisms of action, dosing/administration, and safety considerations.
• Review clinical evidence and current guideline recommendations supporting RSV vaccination in different populations.
• Given a patient case, provide an appropriate recommendation on RSV vaccination.

How to Earn Credit:
Participants must complete the activity as described below in the Continuing Medical Education Statement by reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity consisting of reviewing the monograph, completion of the post-test (minimum score of 70% required; may be taken up to 3 times), activity evaluation, and estimating duration of time spent on the activity. A certificate of completion will be issued after all requirements as described are completed.

Hardware/Software and Internet Requirements can be found at https://medicinece.uic.edu/.

Provider Contact Information:
For general information please email the Office of Continuing Education and Meeting Services at: pharmce@uic.edu. Copyright © 2024– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy